AU2003270625A1 - Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing - Google Patents

Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing

Info

Publication number
AU2003270625A1
AU2003270625A1 AU2003270625A AU2003270625A AU2003270625A1 AU 2003270625 A1 AU2003270625 A1 AU 2003270625A1 AU 2003270625 A AU2003270625 A AU 2003270625A AU 2003270625 A AU2003270625 A AU 2003270625A AU 2003270625 A1 AU2003270625 A1 AU 2003270625A1
Authority
AU
Australia
Prior art keywords
adam15
adam9
vascularization
inhibition
activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003270625A
Other versions
AU2003270625A8 (en
Inventor
Carl P. Blobel
Keisuke Horiuchi
Klaus Preissner
Gisela Weskamp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MANNHEIM/HEIDELBERG, University of
Justus Liebig Universitaet Giessen
Sloan Kettering Institute for Cancer Research
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Publication of AU2003270625A8 publication Critical patent/AU2003270625A8/en
Publication of AU2003270625A1 publication Critical patent/AU2003270625A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003270625A 2002-09-11 2003-09-11 Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing Abandoned AU2003270625A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40985802P 2002-09-11 2002-09-11
US60/409858 2002-09-11
PCT/US2003/028751 WO2004024089A2 (en) 2002-09-11 2003-09-11 Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing

Publications (2)

Publication Number Publication Date
AU2003270625A8 AU2003270625A8 (en) 2004-04-30
AU2003270625A1 true AU2003270625A1 (en) 2004-04-30

Family

ID=31994015

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003270625A Abandoned AU2003270625A1 (en) 2002-09-11 2003-09-11 Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing

Country Status (2)

Country Link
AU (1) AU2003270625A1 (en)
WO (1) WO2004024089A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7309487B2 (en) * 2004-02-09 2007-12-18 George Inana Methods and compositions for detecting and treating retinal diseases
EP1841794B1 (en) * 2005-02-02 2013-11-20 MacroGenics West, Inc. Adam-9 modulators
EP2243488B1 (en) * 2006-01-19 2013-08-14 Eyegene Inc. Pharmaceutical composition for treating vascular-related diseases comprising peptide
GB2453589A (en) * 2007-10-12 2009-04-15 King S College London Protease inhibition
EP2246430B1 (en) * 2008-02-14 2013-12-11 Gene Techno Science Co., Ltd. Anti-adam-15 antibodies and utilization of the same
DK2271668T3 (en) 2008-03-24 2018-03-05 Salman Rahman ADAM-15 ANTIBODIES AND IMMUNOGENEOUS PEPTIDES
US20110306655A1 (en) * 2009-02-19 2011-12-15 Richard Antonius Jozef Janssen Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
JP2013541534A (en) 2010-10-01 2013-11-14 ラーマン，サルマン Methods for generating methodin-selective catalytic cleft specific antibodies for therapeutic and diagnostic applications
WO2019084529A1 (en) * 2017-10-29 2019-05-02 China Medical University ADAM9 inhibitors and the uses thereof
TWI735210B (en) * 2019-04-26 2021-08-01 中國醫藥大學 Use of adam9 inhibitor as immune modulator
CN114578052A (en) * 2022-03-08 2022-06-03 新疆医科大学第一附属医院 Application of ADAM10 in occlusive cardiovascular and cerebrovascular diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1163213A1 (en) * 1999-03-22 2001-12-19 Darwin Discovery Limited Hydroxamic and carboxylic acid derivatives

Also Published As

Publication number Publication date
AU2003270625A8 (en) 2004-04-30
WO2004024089A2 (en) 2004-03-25
WO2004024089A3 (en) 2005-02-03

Similar Documents

Publication Publication Date Title
AU2003224788A1 (en) Method for treatment of tissue
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
AU2003225766A1 (en) Surgical coils and methods of deploying
EP1571969A3 (en) Systems and methods for electrosurgical tissue treatment
AU2003276967A1 (en) Microsurgical tissue treatment system
AU7434101A (en) Treatment of bone diseases
AU2003268531A1 (en) Materials and methods for treatment of allergic diseases
AU2003270625A1 (en) Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing
AU2003267532A1 (en) PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES
AU2003260778A1 (en) Treatment of pipes
AU2003217971A1 (en) Gas-plasma treatment of implants
AU2003259833A1 (en) Methods of treating neurodegenerative diseases
AU2003239184A1 (en) Treatment and inhibition of ocular infections and wounds by cap37 and cap37 peptides
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003256447A1 (en) Treatment of autoimmune skin diseases
AU2003237076A1 (en) Therapeutical use of anti-cd70 antibody for treating or preventing aids
AU2900100A (en) Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss
AU2003222250A1 (en) Treatment of autoimmune diseases
AU2003280688A1 (en) Combination therapy of peptide vaccination and estramustine treatment
AU1405001A (en) Treatment of diseases
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003264954A1 (en) Pharmaceutical composition for prevention and treatment of kidney diseases
AU2003297570A1 (en) Treatment of skin diseases
AU2003272327A1 (en) Methods of bone healing

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase